Do shared breakpoints represent one rearrangement?

Junction confirmation from residual DNA of the original biopsy would establish structure in that specimen, but it would not show that reciprocal copy-number states across trophectoderm and inner cell mass arose from the same rearrangement. That inference needs junction-specific evidence from independently sampled embryo compartments, with assay sensitivity reported for each sample. Does the proposed validation include independent embryo material, or only residual DNA from the first biopsy?

The main limitation is that junction confirmation and tissue distribution answer different questions. Breakpoint-spanning PCR or long-read sequencing could confirm a structural junction in a specimen, but bulk detection would not establish that reciprocal gain and loss arise from that same rearrangement in the relevant cells or across trophectoderm and inner cell mass. That linkage would require cell-resolved or otherwise phased evidence, alongside an assay-specific detection limit for each compartment. Would confirmation be performed on independent embryo material, or only on DNA remaining from the original biopsy?